162. Identifying Determinants of Therapeutic Switch to Linezolid among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

BACKGROUND: In order to target future randomized controlled trials (RCT) of treatment of methicillin-resistant S aureus bloodstream infections (MRSA BSI), it will be important to understand the drivers of antibiotic selection. We aimed to determine factors associated with switching from vancomycin t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Nair, Rajeshwari, Schweizer, Marin L, Perencevich, Eli N, Livorsi, Daniel J, Goto, Michihiko, Alexander, Bruce, Beck, Brice, Richardson, Kelly, Puig-Asensio, Mireia
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809968/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados